Infant Formula Through the Years: Science, Safety, and Clinical Practice

Michelle M. Bohan Brown, PhD, RDN 

Human milk from an infant’s own mother is widely recognized as the gold standard for infant nutrition. However, when breastfeeding is not possible, insufficient, or not the family’s chosen feeding method, health professionals play an important role in helping families select safe, nutritionally appropriate alternatives. Today, there are many options: mom’s own milk supplemented with human milk fortifiers, mixed feeding of a combination of mom’s own milk and formula or donor milk, sole donor human milk, or exclusive infant formula feeding.

From standard formulas for healthy, full-term infants to metabolic formulas for in-born errors of metabolism, infant formulas are developed using extensive scientific knowledge of human milk composition, infant growth and development, and infant physiology and metabolism. As technology and our understanding of infant nutrition advances, formulation of infant formulas can be designed with rigorous testing to ensure safety and nutritional suitability for intended use.

Origin Story — History of Infant Feeding

Before the development of modern infant formula, infants who did not receive human milk from their mother or wet nurse were often fed a variety of foods (gruel, pap, cereal, animal milk) that were not safe, reliable, or nutritionally complete.1,2 As a result, survival rates were poor. For example, in the early 1800s in London, around 10% of non-human milk fed infants survived to age 1.3,4 After the introduction of pasteurization, the benefit of pasteurized milk inspired physicians and scientists to develop milk-based infant formulas that could better support infant growth and survival.1 The first commercial infant formula/food was developed by German chemist Justus von Liebig and consisted of wheat flour, cow’s milk, malt flour, and potassium bicarbonate to correct pH.3 Following the success of von Liebig, others followed suit in the pursuit of producing formula for infants; however, all fell short of success as the nutritional composition was not suitable for infant growth and development. In 1915, synthetic milk adapted (SMA) was developed and was the first sole source formula based on human milk fat content.1 However, there were still issues with micronutrient content that were present from the 1910s through the 1960s.1,5,6 As scientific understanding of infant nutritional requirements and human milk composition has advanced alongside technological innovation, today’s infant formulas are vastly different from those available less than a century ago.

Designed to Meet Infant Needs: Human Milk as Inspiration

Human milk is the gold standard for infant feeding and is the inspiration for formula design. Formula designs and requirements evolve through advancements in knowledge of human milk and infant physiology and technology. Although all mammals produce milk, the composition of lipids, carbohydrates, and proteins varies considerably by species.7 The basis of early formula development focused on milk fat percentage.1 Advances in our ability to characterize the full fatty acid profile of human milk has enabled manufacturers to use multiple fat sources to achieve fatty acid profiles that more closely replicate its composition.8,9  

In replicating human milk fatty acid composition, various sources of lipids are used in infant formulas today. No single ingredient source can replicate human milk; thus, all formulas are a mixture of different lipid sources to achieve a composition closer to human milk (Table 1). As evidenced by fatty acid composition in Table 1, the vegetable oil blend is closer in composition to human milk than the bovine milk fat with corn oil blend. Currently, infant formulas contain vegetable oils in varying amounts with or without bovine milk fat, typically added as whole milk. There are several reasons for the use of vegetable oils in infant formulas. Vegetable oils increase the mono- and polyunsaturated fatty acid content,10 allowing closer patterning to breast milk. In addition, the lower cost and greater availability of vegetable oils allow for more continuous supply and lower cost to consumers.11 As our knowledge of human milk composition has advanced, other lipid sources have been added to infant formulas to pattern after breast milk and better meet the nutritional needs of infants.

One such prominent example of the application of recent scientific discovery is the addition of oils containing docosahexaenoic acid (DHA) in combination with arachidonic acid (ARA) to infant formula in the early 2000s. DHA is naturally present in breast milk and is important for cognitive and visual development in infants.12-14 Research-driven product innovation has also informed the protein and carbohydrates present in formula. Protein sources can be chosen to mimic the whey-to-casein ratio of human milk or more specialized ingredients found more prominently in human milk than cow’s milk, such as alpha-lactalbumin and milk fat globule membrane.15, 16 Formulas in the past 20 years have added carbohydrates beyond lactose and glucose polymers. These additional carbohydrates either mimic or are oligosaccharides found in human milk, which are important for gut microbiota, immunity, and stooling consistency and patterning.17,18,19 Many of the above advances in infant formula composition have occurred in the last quarter of a century.

Table 1: Fatty Acid Composition of Human Milk and Milk Fat and Vegetable Oil Formulas (Prior to Addition of DHA and ARA)*


Fatty Acids (g/100g FA) 

Human Milk (Jensen 1996)

Mature Human Milk (Floris 2020)

Milk Fat Formula*a,b 

Vegetable Oil Formula*a,c 

Saturated FA

C4:0 

0.19 

NR 

3.21 

0.04 

C6:0 

0.15 

0.14 

1.69 

0.21 

C8:0 

0.46 

0.25 

0.99 

2.13 

C10:0 

1.03 

1.61 

2.18 

1.69 

C12:0 

4.4 

6.14 

3.04 

13.07 

C14:0 

6.27 

6.8 

8.62 

5.43 

C15:0 

0.43 

NR 

0.85 

0.05 

C16:0 

22 

22.2 

24.76 

26.5 

C17:0 

0.58 

0.31 

0.43 

0.08 

C18:0 

8.06 

6.46 

8.62 

3.86 

C20:0 

0.44 

0.23 

0.22 

0.26 

C22:0 

0.12 

0.1 

0.11 

NR 

Monounsaturated FA

C14:1  

0.41 

0.2 

0.78 

0.02 

C16:1 

3.29 

2.3 

1.13 

0.16 

C17:1 

0.37 

0.19 

0.18 

0.04 

C18:1 trans isomers 

2.67 

2.03 

2.41 

0.39 

C18:1 cis isomers 

31.3 

32.9 

21.68 

29.74 

C20:1 

0.67 

0.45 

0.1 

0.15 

Polyunsaturated FA

C18:2 all trans isomer 

1.15 

0.12 

2.41 

0.39 

C18:2 n-6  Linoleic 

10.85 

15 

13.89 

14.37 

C18:3 n-3  Linolenic 

1.03 

0.97 

0.71 

1.33 

C20:4 n-6 ARA 

0.46 

0.48 

NR 

NR 

C20:5 n-3 EPA 

0.12 

0.09 

NR 

NR 

C22:6 n-3 DHA 

0.25 

0.31 

NR 

NR 

*Adapted from Berger 2000 (9). Note that these compositions are pre-addition of ARA and DHA to Infant Formulas in the United States.

aInternal data, Nestle Research Centre, Lausanne, Switzerland.

bIngredients are bovine milk fat and corn oil

cIngredients are palmolein, soybean oil, coconut oil and residual amounts of bovine milk fat. 

FA: Fatty Acid

Safety of Infant Formula and Operation Stork Speed

Worldwide regulations for infant formulas have different contaminant, nutritional, and labeling requirements, which can lead to confusion when comparing formulas from different countries and regions.20,21 Prior to the 1980s, the U.S. had no comprehensive federal regulations governing the nutritional quality or safety of infant formula. The Infant Formula Act, enacted in 1980 and strengthened through subsequent amendments, established requirements for formula manufacturing, safety, nutrient composition, quality control, labeling, and reporting.20 Although additional amendments have been proposed, including legislation introduced on March 9, 2026 that remains under consideration,22 the Infant Formula Act continues to provide the regulatory framework for infant formula sold in the U.S. In addition, all infant formulas regardless of production location, must be registered with the FDA and meet federal safety and nutritional standards.23

To introduce a new formula, a growth and tolerance trial is necessary to demonstrate its safety and nutritional suitability, in addition to providing other supporting data. The study follows strict criteria that includes enrollment of exclusively formula-fed infants younger than 2 weeks of age. Infants are followed for 15 weeks with three timepoints within the first month of the study, and once per month thereafter, to evaluate growth, feeding tolerance, and any adverse events.23 Infant formulas introduced prior to 1980 did not necessarily undergo growth and tolerance trials that meet today’s standards, or in some cases, any such studies at all. Evidence of safety for these formulas relies on other supporting scientific evidence and safe history of use from post market surveillance.

Operation Stork Speed was announced in March 2025 to “expand options for safe, reliable, and nutritious infant formula for American families”24 through the thorough review of infant formula nutrients, increased transparency in communication and labeling, increased testing of contaminants and microbiological contaminants in formula, and increased research on infant and maternal nutrition and health outcomes.24 In May 2026, Operation Stork Speed released the results of testing for contaminants in infant formula and human milk.25 This analysis was in conjunction with FDA’s Closer to Zero and FDA’s routine food surveillance work for safe, reliable, and nutritionally suitable infant formula.

In brief, more than 300 infant formula samples available in the U.S. market were tested for lead, mercury, cadmium, arsenic, pesticides, and polyfluoroalkyl substances and phthalates. The vast majority of samples had undetectable or very low levels of contaminants, with all samples having levels of lead, mercury, arsenic, and cadmium lower than EPA requirements for drinking water.26 More than 100 human milk samples from a state milk bank were also tested for lead, arsenic, mercury, and cadmium. The vast majority contained either undetectable or very low levels of these contaminants. For detailed information on methods and outcomes, see FDA’s Infant Formula Product Testing Results.25

Preventing bacterial contamination requires careful manufacturing and handling of both formula and human milk throughout the entire supply chain, from ingredient suppliers and manufacturers to distributors, transport, retailers, health professionals, and parents/guardians/caregivers. Safe infant feeding also depends on proper preparation and storage. Infant formula should always be prepared according to the manufacturer’s instructions or healthcare provider’s recommendations, and neither formula nor breast milk should be diluted.

Achieving contaminant levels that are as low as possible in formula will require coordinated efforts across academia, industry, government, and the public. Advances in testing methods and technology are also necessary to improve the detection of contaminants in both ingredients and finished formula products. Detecting specific contaminants in finished formulas is challenging because these products contain numerous ingredients, all bearing different compositions, matrices, and potential contaminants.27 Additionally, all assays have limits of detection and limitations of sample composition/preparation, which can affect the ability to detect contaminants.

There are other factors beyond scientific evidence and safety regulations that must be met to ensure safe infant feeding and reduce contamination. Contaminants are present in our water, food/ingredients, and environment. Lowering contaminants in ingredients, formula, and human milk would require lower contaminants in the environment, food sources, and water. Infant formulas are evolving as science and technology advance. Together, we can improve the health and safety of nutrition for infants.

See All Articles in this issue

References
  1. Anderson SA, Chinn HI, Fisher KD. History and current status of infant formulas. Am J Clin Nutr. 1982 Feb;35(2):381-97. doi: 10.1093/ajcn/35.2.381. PMID: 7039294.  
  2. Obladen M. Pap, gruel, and panada: early approaches to artificial infant feeding. Neonatology. 2014;105(4):267-74. doi: 10.1159/000357935. Epub 2014 Feb 26. PMID: 24577423.  
  3. Cone TE Jr. 200 Years of feeding infants in America. Columbus, OH: Ross Laboratories, 1976.  
  4. Forsyth D. The History of Infant-feeding from Elizabethan Times. Proc R Soc Med. 1911;4:110–141. doi: 10.1177/003591571100401457.  
  5. Hess AF. Newer aspects of some nutritional disorders. JAMA. 1921;76(11):693–700. doi:10.1001/jama.1921.02630110001001.  
  6. Zuelzer WW, Rutzky J. Megaloblastic anemia of infancy. Adv Pediatr. 1953;6:243-306. PMID: 13080017.  
  7. Pietrzak-Fiećko R, Kamelska-Sadowska AM. The Comparison of Nutritional Value of Human Milk with Other Mammals' Milk. Nutrients. 2020 May 14;12(5):1404. doi: 10.3390/nu12051404. PMID: 32422857; PMCID: PMC7284997.  
  8. L.M. Floris, B. Stahl, M. Abrahamse-Berkeveld, I.C. Teller. Human milk fatty acid profile across lactational stages after term and preterm delivery: A pooled data analysis. PLEFA. 2020;156:102023. doi:10.1016/j.plefa.2019.102023.  
  9. Berger A, Fleith M, Crozier G. Nutritional implications of replacing bovine milk fat with vegetable oil in infant formulas. J Pediatr Gastroenterol Nutr. 2000 Feb;30(2):115-30. doi: 10.1097/00005176-200002000-00006.   
  10. Innis SM. Dietary Triacylglycerol Structure and Its Role in Infant Nutrition. Adv Nutr. 2011;2(3):275-283.  
  11. Hageman JHJ, Danielsen M, Nieuwenhuizen AG, Feitsma AL, Dalsgaard TK. Comparison of bovine milk fat and vegetable fat for infant formula: Implications for infant health. Intl Dairy J. 2019 92:37-49.  
  12. Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr. 2007 Jun;85(6):1457-64. doi: 10.1093/ajcn/85.6.1457.   
  13. Birch, E., Hoffman, D., Uauy, R. et al. Visual Acuity and the Essentiality of Docosahexaenoic Acid and Arachidonic Acid in the Diet of Term Infants. Pediatr Res. 1998;44, 201–209.  
  14. Colombo J, Carlson SE, Cheatham CL, et al. Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr. 2013;98:403-412.  
  15. Chauvet L, Charton E, Lemaire M, Le Huërou-Luron I, Deglaire A. Human milk vs. cow-milk based infant formula proteins: structure, digestion and physiological impacts. Front Nutr. 2025 Aug 18;12:1635919. doi: 10.3389/fnut.2025.1635919.  
  16. Kocyigit E, Çelik E, Cemali Ö, Karaca OB, Raposa B, Ağagündüz D. Milk fat globule membrane in early-life nutrition: composition, production, and biological effects on infant immune maturation, intestinal development, neurocognitive function, and growth. Front Nutr. 2026 Jun 18;13:1851487. doi: 10.3389/fnut.2026.1851487.  
  17. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008 Jun;138(6):1091-5.   
  18. Akkerman R, Faas MM, de Vos P. Non-digestible carbohydrates in infant formula as substitution for human milk oligosaccharide functions: Effects on microbiota and gut maturation. Crit Rev Food Sci Nutr. 2019;59(9):1486-1497. doi: 10.1080/10408398.2017.1414030.   
  19. Scalabrin DM, Mitmesser SH, Welling GW, et al. New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants. Journal of Pediatric Gastroenterology and Nutrition. 2012 Mar;54(3):343-352. DOI: 10.1097/mpg.0b013e318237ed95.  
  20. 21 CFR Infant Formula Act 1.107 (1985).  
  21. Codex Alimentarius Commission. (2024). Standard for infant formula and formulas for special medical purposes intended for infants (CXS 72-1981). Food and Agriculture Organization of the United Nations.  
  22. H.R.7867 - 119th Congress (2025-2026): Infant Formula Safety Modernization Act of 2026 | Congress.gov | Library of Congress.  
  23. 21 USC 350a: Infant formulas (2026).  
  24. https://www.fda.gov/food/infant-formula-homepage/operation-stork-speed. Accessed June 30, 2026.  
  25. https://www.fda.gov/food/infant-formula-homepage/fdas-infant-formula-product-testing-results. Accessed June 30, 2026.  
  26. https://www.epa.gov/ground-water-and-drinking-water/national-primary-drinking-water-regulations. Accessed June 30, 2026.  
  27. Williams ML, Olomukoro AA, Emmons RV, Godage NH, Gionfriddo E. Matrix effects demystified: Strategies for resolving challenges in analytical separations of complex samples. J Sep Sci. 2023 Dec;46(23):e2300571. doi: 10.1002/jssc.202300571.  

Michelle M. Bohan Brown


PhD, RDN 

Michelle M. Bohan Brown, PhD, RDN, is a scientific consultant residing in the Little Rock, AR area and has over 20 years of nutrition research experience in academia and industry. Her experience spans dietary composition, endocrine responses, and obesity-related outcomes in adults and children and functional ingredients in infant formula.

    Soy Connection logo